AbSci

Jan 07, 2021

AbSci to Present at the 39th Annual J.P. Morgan Healthcare Conference

Nov 11, 2020

AbSci Announces Recent Additions to Board of Directors

Oct 20, 2020

AbSci Announces $65 Million Financing Led by Casdin Capital

Oct 15, 2020

AbSci CEO Sean McClain Named as an Entrepreneur Of The Year® 2020 Pacific Northwest Region Award Winner

Jul 21, 2020

Alpha Cancer Technologies to License AbSci's SoluPro Strain for the Expression of Alpha-Fetoprotein

May 11, 2020

AbSci Appoints Greg Schiffman As Chief Financial Officer

Apr 05, 2019

AbSci Develops Game-Changing 12-Week Cell Line Optimization Workflow and Adds Two New Members to Its Executive Team

Jan 09, 2019

AbSci Establishes New Collaboration with Sanofi

Oct 02, 2018

AbSci Appoints Andrew J.S. Jones, D. Phil to Scientific Advisory Board

May 30, 2018

AbSci Raises Oversubscribed $12M Series C to Fuel Commercialization of Its Groundbreaking Protein Expression Platform

Feb 05, 2018

AbSci Appoints Alan Herman, PhD to Scientific Advisory Board

Jan 09, 2018

AbSci Appoints William F. Bennett, PhD to Scientific Advisory Board

Dec 22, 2017

AbSci Appoints Fred Larimore, PhD to Scientific Advisory Board